Literature DB >> 9839309

A study of proliferative markers in central neurocytoma.

M C Sharma1, A Rathore, A K Karak, C Sarkar.   

Abstract

To gain a better insight into the biological behavior of central neurocytomas, various proliferative indices were studied in these tumors and correlated with the histological features as well as the clinical outcome. Twenty cases of neurocytoma were selected over a 16 year period (1980-1995), which accounted for 0.28% of all intracranial tumors reported at this centre. Treatment consisted of surgical resection (total 14, subtotal six) followed by radiotherapy. Except for five patients who died of surgical complications, the remaining 15 were all alive and well during the follow-up period, varying from six months to 72 months (average 32 months). Thirteen tumors showed benign histological characteristics (Group I) while seven showed mitoses + necrosis (Group II). The proliferative index was assessed in formalin-fixed paraffin-embedded tissue of 17 cases using the silver nucleolar organiser region (AgNOR) technique and immunohistochemical staining for proliferating cell nuclear antigen (PCNA-PC10 antibody) and Ki-67 antigen (MIB-1 monoclonal antibody). The AgNOR counts ranged from 1.2 to 2.6 (mean 1.9 +/- 0.4), PCNA labeling index (LI) from 0.1 to 5.5 (mean 2.5 +/- 1.8) and MIB-1 LI from 0.1 to 3 (mean 0.8 +/- 0.02). There was no significant difference in any of these parameter values between histological Groups I and II, except that MIB-1 LI tended to be higher in Group II tumors. Further, there was no significant correlation between these proliferative indices and the mitotic rate of the tumors as well as the survival of the patients. A longer follow-up will be required to determine the relationship between proliferative markers and outcome as well as to bring out any heterogeneity in their biological behavior. Since these are relatively rare tumors, multicentric pooling of data will be required to reach a definitive consensus regarding their biological aggressiveness and consequentially, the use of radiotherapy in their treatment. The present report is a contribution in this direction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839309     DOI: 10.1080/00313029800169626

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  20 in total

Review 1.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

2.  Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.

Authors:  Petra Mozes; Erika Szanto; Laszlo Tiszlavicz; Pal Barzo; Adrienne Cserhati; Emese Fodor; Katalin Hideghety
Journal:  Pathol Oncol Res       Date:  2013-10-12       Impact factor: 3.201

Review 3.  Central neurocytoma with craniospinal dissemination.

Authors:  Hidemasa Takao; Keiichi Nakagawa; Kuni Ohtomo
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

4.  Atypical neurocytoma of the spinal cord in a young child.

Authors:  Avninder Singh; Karam Chand; Hukum Singh; Chitra Sarkar; Mehar C Sharma
Journal:  Childs Nerv Syst       Date:  2006-07-13       Impact factor: 1.475

5.  Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report.

Authors:  A Bertalanffy; K Roessler; W Dietrich; M Aichholzer; D Prayer; A Ertl; K Kitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

6.  Neurocytomas: long-term experience of a single institution.

Authors:  A Hallock; B Hamilton; L C Ang; K Y Tay; J F Meygesi; B J Fisher; C J Watling; D R Macdonald; G S Bauman
Journal:  Neuro Oncol       Date:  2011-08-08       Impact factor: 12.300

7.  Primary neurocytoma of the spinal cord: a case report and review of literature.

Authors:  Suash Sharma; Chitra Sarkar; Shailesh Gaikwad; Ashish Suri; Mehar C Sharma
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

8.  Youngest case of third ventricular anaplastic neurocytoma.

Authors:  Chinnikatti Shravan Kumar; D N Sharma; Kuldeep Sharma; K P Haresh; G K Rath
Journal:  Indian J Med Paediatr Oncol       Date:  2010-04

9.  Rapid shrinkage of remnant central neurocytoma after gamma knife radiosurgery: a case report.

Authors:  Mutsuya Hara; Masaru Aoyagi; Masaaki Yamamoto; Taketoshi Maehara; Yoshiaki Takada; Takeko Nojiri; Kikuo Ohno
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Pathologic features and clinical outcome of central neurocytoma: analysis of 15 cases.

Authors:  Yu Li; Xiu-Feng Ye; Guo Qian; Yu Yin; Qian-Guan Pan
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.